UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934
(Amendment No. 21)*

iBio, Inc.

(Name of Issuer)

COMMON STOCK, $0.0010 PAR VALUE PER SHARE

(Title of Class of Securities)

451033203

(CUSIP Number)

William Sullivan, 10 Market Street, #773 Camana Bay Grand Cayman, KY1-9006 CAYMAN ISLANDS, 345-640-3300

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

August 12, 2020

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ¨

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 
 

 

 
CUSIP No. 451033203   13D/A   Page 2 of 8
         
1.   NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

EASTERN CAPITAL LIMITED
   
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a)    ¨
(b)    ¨
   
3.   SEC USE ONLY
 
   
4.   SOURCE OF FUNDS (see instructions)
 
WC
   
5.  

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

¨

   
6.   CITIZENSHIP OR PLACE OF ORGANIZATION
 
CAYMAN ISLANDS
   
         
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   7.   SOLE VOTING POWER
 
-0-
  8.   SHARED VOTING POWER
 
 1,000,000
  9.   SOLE DISPOSITIVE POWER
 
-0-
  10.   SHARED DISPOSITIVE POWER
 
 1,000,000
         
11.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,000,000
   
12.   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(see instructions)    ¨
   
13.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

0.6%
   
14.   TYPE OF REPORTING PERSON (see instructions)

CO
   
                         

 

 
 

 

 
CUSIP No. 451033203   13D/A   Page 3 of 8
         
1.   NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

PORTFOLIO SERVICES LTD.
   
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a)    ¨
(b)    ¨
   
3.   SEC USE ONLY
 
   
4.   SOURCE OF FUNDS (see instructions)
 
OO
   
5.  

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

¨

   
6.   CITIZENSHIP OR PLACE OF ORGANIZATION
 
CAYMAN ISLANDS
   
         
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   7.   SOLE VOTING POWER
 
-0-
  8.   SHARED VOTING POWER
 
 1,000,000
  9.   SOLE DISPOSITIVE POWER
 
-0-
  10.   SHARED DISPOSITIVE POWER
 
 1,000,000
         
11.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 1,000,000
   
12.   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(see instructions)    ¨
   
13.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

0.6%
   
14.   TYPE OF REPORTING PERSON (see instructions)

CO
   
                         
 
 

 

 
CUSIP No. 451033203   13D/A   Page 4 of 8
         
1.   NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

KENNETH B. DART
   
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a)    ¨
(b)    ¨
   
3.   SEC USE ONLY
 
   
4.   SOURCE OF FUNDS (see instructions)
 
OO
   
5.  

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

¨

   
6.   CITIZENSHIP OR PLACE OF ORGANIZATION
 
CAYMAN ISLANDS
   
         
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   7.   SOLE VOTING POWER
 
-0-
  8.   SHARED VOTING POWER
 
1,000,000
  9.   SOLE DISPOSITIVE POWER
 
-0-
  10.   SHARED DISPOSITIVE POWER
 
 1,000,000
         
11.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 1,000,000
   
12.   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(see instructions)    ¨
   
13.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

0.6%
   
14.   TYPE OF REPORTING PERSON (see instructions)

IN
   
                         

 

 
 

 

 
         
CUSIP No. 451033203   13D/A   Page 5 of 8

 

Explanatory Note: This Amendment No. 21 to Schedule 13D (this “Amendment No. 21”) relates to shares of common stock, par value $0.001 per share (the “Common Stock”), of iBio, Inc., (the “Issuer”). This Amendment No. 21 amends the original Schedule 13D filed with the U.S. Securities and Exchange Commission (“SEC”) by the Reporting Persons as previously amended by Amendments No. 1 through 20 (the “Schedule 13D”). Except as otherwise specified in this Amendment No. 21, all previous Items are unchanged. Defined terms used herein but not otherwise defined have the meanings set forth in the Schedule 13D.

Item 4. Purpose of Transaction.

On August 12, 2020, the Reporting Persons sold an aggregate 7,629,693 of the shares of the Issuer’s Common Stock in open market transactions.

The Reporting Persons intend generally to dispose of additional shares of Common Stock, subject to various factors, including but not limited to market conditions and other factors that the Reporting Persons may deem relevant to their investment decisions. However, the Reporting Persons have no specific plans or proposals to dispose of any specific number of shares of Common Stock or at any specific prices and the Reporting Persons reserve the right to change their current intentions. Except as otherwise described above, the Reporting Persons have no plans or proposals that relate to or would result in any transaction, event or action enumerated in paragraph (a) through (j) of Item 4 of Schedule 13D.

Item 5.  Interest in Securities of the Issuer.

Item 5(a) (b) and (c)

As of the date hereof, Eastern Capital Limited beneficially owns 1,000,000 shares of the Issuer’s Common Stock, representing 0.6% of the Issuer’s outstanding Common Stock. Eastern Capital Limited has shared voting and dispositive power of the shares it beneficially owns with its parent, Portfolio Services Ltd., and Kenneth B. Dart.

Portfolio Services Ltd., as the owner of all of the outstanding shares of Eastern Capital Limited, indirectly beneficially owns 1,000,000 shares of the Issuer’s Common stock, representing 0.6% of the Issuer’s outstanding Common Stock. Portfolio Services Ltd. has shared voting and dispositive power of the shares it beneficially owns.

As a result of Kenneth B. Dart’s ownership of all of the outstanding shares of Portfolio Services Ltd., he indirectly beneficially owns 1,000,000 shares of the Issuer’s Common Stock, representing 0.6% of the Issuer’s outstanding Common Stock. Kenneth B. Dart has shared voting and dispositive power of the shares he beneficially owns.

The percentage ownership is based on 174,415,206 shares of Common Stock outstanding, as at August 12, 2020, and as reported in the Issuer‘s Form 8-K, dated August 13, 2020, and filed with the U.S. Securities Exchange Commission on August 13, 2020.

In the past 60 days, the following sales of shares of the Common Stock were effected in open market transactions by Eastern Capital Limited (the only Reporting Person to effect any such transactions) during the period August 4, 2020, through August 12, 2020:

 
 

 

 
         
CUSIP No. 451033203   13D/A   Page 6 of 8

 

Date Number of Shares Sold Weighted Average Selling Price
August 4, 2020 600,000 4.3944 1
August 5, 2020 900,000 4.4595 2
August 6, 2020 2,768,137 4.1799 3
August 7, 2020 1,355,604 3.8253 4
August 10, 2020 7,264,864 3.9133 5
August 11, 2020 15,864,436 2.9204 6
August 12, 2020 7,629,693 2.50597

 

(1) The Price reported is a weighted average price. These shares of Common Stock were sold through a broker dealer in multiple transactions at prices ranging from $ 4.32 to $4.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
(2) The Price reported is a weighted average price. These shares of Common Stock were sold through a broker dealer in multiple transactions at prices ranging from $4.36 to $4.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
(3) The Price reported is a weighted average price. These shares of Common Stock were sold through a broker dealer in multiple transactions at prices ranging from $4.05 to $4.52. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request
(4) The Price reported is a weighted average price. These shares of Common Stock were sold through a broker dealer in multiple transactions at prices ranging from $3.62 to $4.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request
(5) The Price reported is a weighted average price. These shares of Common Stock were sold through a broker dealer in multiple transactions at prices ranging from $3.65 to $4.53. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request
(6) The Price reported is a weighted average price. These shares of Common Stock were sold through a broker dealer in multiple transactions at prices ranging from $2.69 to $3.69. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request
(7) The Price reported is a weighted average price. These shares of Common Stock were sold through a broker dealer in multiple transactions at prices ranging from $2.34 to $2.93. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request

 

On August 6, 2020, Eastern Capital Limited delivered to the Issuer a notice of conversion of the Series B Preferred Stock held by Eastern Capital Limited with effect on August 7, 2020. As a result, the Series B Preferred Stock was converted into 28,925,000 shares of Common Stock based on the conversion price of $0.20.

 
 

 

 
         
CUSIP No. 451033203   13D/A   Page 7 of 8

 

Item 5 (d) Not Applicable

Item 5 (e)

On August 12, 2020, the Reporting Persons ceased to be the beneficial owner of more than five percent of the shares of Common Stock of the Issuer.

 

Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

Item 6 is hereby amended and supplemented as follows:

The information set forth in Item 4 of this Amendment No. 21 is incorporated by reference into this Item 6.

 

Item 7. Material to Be Filed as Exhibits.

Exhibit 1 – Joint Filing Agreement

 

 
 

 

 
CUSIP No. 451033203   13D/A   Page 8 of 8

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Eastern Capital Limited

08/13/2020

Date

 

/s/ Kenneth B. Dart

Signature

 

Kenneth B. Dart, Director

Name/Title

 
Portfolio Services Ltd.

08/13/2020

Date

 

/s/ Kenneth B. Dart

Signature

 

Kenneth B. Dart, Director

Name/Title

 
Kenneth B. Dart

08/13/2020

Date

 

/s/ Kenneth B. Dart

Signature

 

Kenneth B. Dart

Name/Title

         
 

 

iBio (AMEX:IBIO)
Historical Stock Chart
From Oct 2020 to Nov 2020 Click Here for more iBio Charts.
iBio (AMEX:IBIO)
Historical Stock Chart
From Nov 2019 to Nov 2020 Click Here for more iBio Charts.